Clinical trial
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
NCT00470262 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00470262 |
|---|---|
| Title | Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation |
| Official title | Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation in Subjects With Impaired Glucose Tolerance |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X, Prediabetic State |
| Intervention type | Drug |
| Interventions | Fenofibrate 145mg PO QD, Pioglitazone 45 mg PO QD |
| Enrollment | 27 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2012 |
| Completion | Jun 1, 2014 |
| First posted | May 7, 2007 |
| Last update posted | Jul 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: